The positive correlation between RNA-seq and immunohistochemistry (IHC) in NCI-ACC patient samples suggests that SEMA7A could be a promising prognostic biomarker for clinical applications. The gene discussed is SEMA7A; the disease is adrenal cortex carcinoma.